Hiroomi Watabe

693 total citations
28 papers, 590 citations indexed

About

Hiroomi Watabe is a scholar working on Molecular Biology, Pharmacology and Molecular Medicine. According to data from OpenAlex, Hiroomi Watabe has authored 28 papers receiving a total of 590 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Pharmacology and 6 papers in Molecular Medicine. Recurrent topics in Hiroomi Watabe's work include Microbial Natural Products and Biosynthesis (7 papers), Antibiotic Resistance in Bacteria (6 papers) and Cancer therapeutics and mechanisms (5 papers). Hiroomi Watabe is often cited by papers focused on Microbial Natural Products and Biosynthesis (7 papers), Antibiotic Resistance in Bacteria (6 papers) and Cancer therapeutics and mechanisms (5 papers). Hiroomi Watabe collaborates with scholars based in Japan, United States and United Kingdom. Hiroomi Watabe's co-authors include Minako Araake, Shigeru Morikawa, K. Morikawa, Takehiko Shibata, Tadahiko Ando, TAKASHI SHOMURA, Masaji Sezaki, Shinichi Kondo, T Iino and HARUO YAMAMOTO and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Hiroomi Watabe

27 papers receiving 556 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroomi Watabe Japan 14 292 164 95 81 80 28 590
Katsuhisa Nakata Japan 15 204 0.7× 184 1.1× 147 1.5× 41 0.5× 128 1.6× 28 710
Ikuko Tomiyasu Japan 13 364 1.2× 75 0.5× 114 1.2× 64 0.8× 45 0.6× 17 544
Wdee Thienphrapa United States 9 205 0.7× 102 0.6× 57 0.6× 63 0.8× 70 0.9× 10 497
Siegfried Raddatz Germany 12 433 1.5× 152 0.9× 35 0.4× 183 2.3× 36 0.5× 21 782
Joenel Alcantara Canada 11 295 1.0× 105 0.6× 45 0.5× 46 0.6× 19 0.2× 16 522
Junzo Mizoguchi Japan 8 228 0.8× 82 0.5× 33 0.3× 36 0.4× 42 0.5× 11 481
Sufi Morshed Japan 17 197 0.7× 59 0.4× 50 0.5× 99 1.2× 222 2.8× 22 697
Beth Andrews United States 10 396 1.4× 47 0.3× 42 0.4× 88 1.1× 186 2.3× 13 705
R. J. McRipley United States 11 245 0.8× 69 0.4× 79 0.8× 124 1.5× 201 2.5× 17 712
S.C. Mosimann Canada 14 585 2.0× 58 0.4× 59 0.6× 107 1.3× 56 0.7× 18 969

Countries citing papers authored by Hiroomi Watabe

Since Specialization
Citations

This map shows the geographic impact of Hiroomi Watabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroomi Watabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroomi Watabe more than expected).

Fields of papers citing papers by Hiroomi Watabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroomi Watabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroomi Watabe. The network helps show where Hiroomi Watabe may publish in the future.

Co-authorship network of co-authors of Hiroomi Watabe

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroomi Watabe. A scholar is included among the top collaborators of Hiroomi Watabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroomi Watabe. Hiroomi Watabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Watabe, Hiroomi, et al.. (2004). Optimization of dose and dose regimen of biapenem based on pharmacokinetic and pharmacodynamic analysis. Journal of Infection and Chemotherapy. 10(2). 76–85. 28 indexed citations
2.
Tsuruoka, Tsutomu, et al.. (2003). [Activity of fosfomycin against Escherichia coli O157:H7--morphological changes and production of Shiga toxins].. PubMed. 56(6). 691–6. 3 indexed citations
3.
Nosé, Hiroshi, et al.. (2002). PF1163A, a Novel Antifungal Agent, Inhibit Ergosterol Biosynthesis at C-4 Sterol Methyl Oxidase.. The Journal of Antibiotics. 55(11). 969–974. 16 indexed citations
4.
Maebashi, Kazunori, et al.. (2002). [Inhibitory activity of NM394, the active form of prodrug prulifloxacin against type II topoisomerase from Pseudomonas aeruginosa].. PubMed. 55(6). 882–5. 3 indexed citations
5.
Araake, Minako, et al.. (2002). [In vitro antibacterial activity of prulifloxacin, a new oral fluoroquinolone].. PubMed. 55(6). 778–90. 3 indexed citations
6.
Watanabe, M., Tamio Hiratani, Hiroomi Watabe, et al.. (1997). Mode of Antifungal Action of Benanomicin A in Saccharomyces cerevisiae.. The Journal of Antibiotics. 50(12). 1042–1051. 11 indexed citations
7.
Watabe, Hiroomi. (1997). Antibiotic Fosfomycin; It's Small but has Potential for the Future.. Journal of Synthetic Organic Chemistry Japan. 55(3). 229–234.
8.
Watanabe, M., Tamio Hiratani, Katsuhisa Uchida, et al.. (1996). The in-vitro activity of an antifungal antibiotic benanomicin A in comparison with amphotericin B. Journal of Antimicrobial Chemotherapy. 38(6). 1073–1077. 11 indexed citations
9.
Morikawa, K., Hiroomi Watabe, Minako Araake, & Shigeru Morikawa. (1996). Modulatory effect of antibiotics on cytokine production by human monocytes in vitro. Antimicrobial Agents and Chemotherapy. 40(6). 1366–1370. 178 indexed citations
10.
Watabe, Hiroomi, Shigeharu Inouye, Shigeru Abe, et al.. (1996). Antifungal Antibiotic Benanomicin A Increases Susceptibility of Candida albicans to Phagocytosis by Murine Macrophages.. The Journal of Antibiotics. 49(12). 1221–1225. 4 indexed citations
11.
Hatsu, Masahiro, Tōru Sasaki, Hiroomi Watabe, et al.. (1992). A new tetracycline antibiotic with antitumor activity. I. Taxonomy and fermentation of the producing strain, isolation and characterization of SF2575.. The Journal of Antibiotics. 45(3). 320–324. 27 indexed citations
12.
Hatsu, Masahiro, Toru Sasaki, Shinji Miyadoh, et al.. (1990). SF2487, a new polyether antibiotic produced by Actinomadura.. The Journal of Antibiotics. 43(3). 259–266. 13 indexed citations
13.
Watabe, Hiroomi, Tadashi Nakazawa, TAKASHI SHOMURA, et al.. (1989). Ankinomycin, a potent antitumor antibiotic.. The Journal of Antibiotics. 42(1). 149–152. 13 indexed citations
14.
Itoh, Jiro, Hiroomi Watabe, Shigetaka Ishii, et al.. (1988). Sibanomicin, a new pyrrolo(1,4)benzodiazepine antitumor antibiotic produced by a Micromonospora sp.. The Journal of Antibiotics. 41(9). 1281–1284. 18 indexed citations
15.
Watabe, Hiroomi, Tōru Sasaki, Yasuo Takeuchi, et al.. (1988). Pyrindamycins A and B, new antitumor antibiotics.. The Journal of Antibiotics. 41(10). 1515–1519. 42 indexed citations
16.
Shibata, Takehiko, Hiroomi Watabe, Takahiro Kaneko, T Iino, & Tsuyoshi Ando. (1984). On the nucleotide sequence recognized by a eukaryotic site-specific endonuclease, Endo.SceI from yeast.. Journal of Biological Chemistry. 259(16). 10499–10506. 28 indexed citations
17.
Watabe, Hiroomi, T Iino, Takahiro Kaneko, Takehiko Shibata, & Takao Ando. (1983). A new class of site-specific endodeoxyribonucleases. Endo.Sce I isolated from a eukaryote, Saccharomyces cerevisiae.. Journal of Biological Chemistry. 258(8). 4663–4665. 35 indexed citations
18.
Shibata, Takehiko, et al.. (1982). ATP-dependent unwinding of double helix in closed circular DNA by RecA protein of E. coli. Nature. 299(5878). 86–89. 53 indexed citations
19.
Nojiri, Chuhei, et al.. (1980). Isolation and characterization of plasmids from parent and variant strains of Streptomyces ribosidificus.. The Journal of Antibiotics. 33(1). 118–121. 17 indexed citations
20.
Homma, J Y, Hiroomi Watabe, & Yoshinari Tanabe. (1968). The temperate phages having a serological relationship with the phage bound pyocine.. PubMed. 38(3). 213–24. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katsuhisa Nakata Breakdown of academic impact, for papers by Ikuko Tomiyasu Breakdown of academic impact, for papers by Wdee Thienphrapa Breakdown of academic impact, for papers by Siegfried Raddatz Breakdown of academic impact, for papers by Joenel Alcantara Breakdown of academic impact, for papers by Junzo Mizoguchi Breakdown of academic impact, for papers by Sufi Morshed Breakdown of academic impact, for papers by Beth Andrews Breakdown of academic impact, for papers by R. J. McRipley Breakdown of academic impact, for papers by S.C. Mosimann
Rankless by CCL
2026